Skip to content
10-Q

Quarterly Report

LIPOSCIENCE INC

0001168197-14-000047

← back to feed
Filed
Aug 13, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 8, 2014 15.28M sh
Capex Q2 2014 · Jun 30, 2014 $3.46M
Capex Q2 2014 · Jun 30, 2013 $1.92M
Long Term Debt Q2 2014 · Jun 30, 2014 $13.44M
Long Term Debt Q2 2014 · Dec 31, 2013 $0
Short Term Debt Q2 2014 · Jun 30, 2014 $2.41M
Short Term Debt Q2 2014 · Dec 31, 2013 $0
Cash And Equivalents Q2 2014 · Jun 30, 2014 $42.79M
Cash And Equivalents Q2 2014 · Dec 31, 2013 $49.57M
Cash And Equivalents Q2 2014 · Jun 30, 2013 $54.25M
Cash And Equivalents Q2 2014 · Dec 31, 2012 $24.77M
Stockholders Equity Q2 2014 · Jun 30, 2014 $42.42M
Stockholders Equity Q2 2014 · Dec 31, 2013 $47.76M
Current Liabilities Q2 2014 · Jun 30, 2014 $7.79M
Current Liabilities Q2 2014 · Dec 31, 2013 $21.61M
Total Liabilities Q2 2014 · Jun 30, 2014 $23.8M
Total Liabilities Q2 2014 · Dec 31, 2013 $24.24M
Current Assets Q2 2014 · Jun 30, 2014 $48.43M
Current Assets Q2 2014 · Dec 31, 2013 $56.59M
Total Assets Q2 2014 · Jun 30, 2014 $66.22M
Total Assets Q2 2014 · Dec 31, 2013 $72M
Sga Expense Q2 2014 · Jun 30, 2014 $3.18M
Sga Expense Q2 2014 · Jun 30, 2014 $6.52M
Sga Expense Q2 2014 · Jun 30, 2013 $2.77M
Sga Expense Q2 2014 · Jun 30, 2013 $6.08M
Rd Expense Q2 2014 · Jun 30, 2014 $2.06M
Rd Expense Q2 2014 · Jun 30, 2014 $4.62M
Rd Expense Q2 2014 · Jun 30, 2013 $3.12M
Rd Expense Q2 2014 · Jun 30, 2013 $6.25M
Net Income Q2 2014 · Jun 30, 2014 −$4.06M
Net Income Q2 2014 · Jun 30, 2014 −$6.1M
Net Income Q2 2014 · Jun 30, 2013 −$2.44M
Net Income Q2 2014 · Jun 30, 2013 −$5.29M
Operating Income Q2 2014 · Jun 30, 2014 −$3.63M
Operating Income Q2 2014 · Jun 30, 2014 −$5.24M
Operating Income Q2 2014 · Jun 30, 2013 −$2M
Operating Income Q2 2014 · Jun 30, 2013 −$4.33M
Gross Profit Q2 2014 · Jun 30, 2014 $6.58M
Gross Profit Q2 2014 · Jun 30, 2014 $15.98M
Gross Profit Q2 2014 · Jun 30, 2013 $10.7M
Gross Profit Q2 2014 · Jun 30, 2013 $21.46M